PuSH - Publikationsserver des Helmholtz Zentrums München

Evans, D.M.* ; Brion, M.J.* ; Paternoster, L.* ; Kemp, J.P.* ; McMahon, G.* ; Munafò, M.* ; Whitfield, J.B.* ; Medland, S.E.* ; Montgomery, G.W.* ; GIANT Consortium (Gieger, C. ; Grallert, H. ; Heid, I.M. ; Heinrich, J. ; Illig, T. ; Peters, A. ; Wichmann, H.-E.) ; CRP Consortium (Baumert, J.J.) ; TAG Consortium (*) ; Timpson, N.J.* ; St. Pourcain, B.* ; Lawlor, D.A.* ; Martin, N.G.* ; Dehghan, A.* ; Hirschhorn, J.* ; Davey Smith, G.*

Mining the human phenome using allelic scores that index biological intermediates.

PLoS Genet. 9:e1003919 (2013)
Verlagsversion Volltext DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
It is common practice in genome-wide association studies (GWAS) to focus on the relationship between disease risk and genetic variants one marker at a time. When relevant genes are identified it is often possible to implicate biological intermediates and pathways likely to be involved in disease aetiology. However, single genetic variants typically explain small amounts of disease risk. Our idea is to construct allelic scores that explain greater proportions of the variance in biological intermediates, and subsequently use these scores to data mine GWAS. To investigate the approach's properties, we indexed three biological intermediates where the results of large GWAS meta-analyses were available: body mass index, C-reactive protein and low density lipoprotein levels. We generated allelic scores in the Avon Longitudinal Study of Parents and Children, and in publicly available data from the first Wellcome Trust Case Control Consortium. We compared the explanatory ability of allelic scores in terms of their capacity to proxy for the intermediate of interest, and the extent to which they associated with disease. We found that allelic scores derived from known variants and allelic scores derived from hundreds of thousands of genetic markers explained significant portions of the variance in biological intermediates of interest, and many of these scores showed expected correlations with disease. Genome-wide allelic scores however tended to lack specificity suggesting that they should be used with caution and perhaps only to proxy biological intermediates for which there are no known individual variants. Power calculations confirm the feasibility of extending our strategy to the analysis of tens of thousands of molecular phenotypes in large genome-wide meta-analyses. We conclude that our method represents a simple way in which potentially tens of thousands of molecular phenotypes could be screened for causal relationships with disease without having to expensively measure these variables in individual disease collections.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Genome-wide Association; C-reactive Protein; Mendelian Randomization Analysis; Coronary-heart-disease; Body-mass Index; Complex Traits; Genetic Epidemiology; Bariatric Surgery; Blood-pressure; Common Snps
ISSN (print) / ISBN 1553-7390
e-ISSN 1553-7404
Zeitschrift PLoS Genetics
Quellenangaben Band: 9, Heft: 10, Seiten: , Artikelnummer: e1003919 Supplement: ,
Verlag Public Library of Science (PLoS)
Verlagsort San Francisco
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Genetic Epidemiology (IGE)
Institute of Epidemiology (EPI)
Research Unit Molecular Epidemiology (AME)
Institute of Epidemiology II (EPI2)